Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Binhu Shuanghe Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in large-volume parenterals (LVP) and intravenous solutions. Based in Wuhan, the company operates as a core subsidiary of China Resources Double-Crane Pharmaceutical, leveraging advanced production lines for glass bottles, plastic bottles, and flexible bags. Its extensive product portfolio includes basic infusions, therapeutic infusions, and nutritional injections used widely in clinical settings for fluid and electrolyte management. The company maintains rigorous GMP standards and plays a vital role in the supply chain for essential medicines in Central China. With a history dating back to 1958, it combines decades of manufacturing expertise with modern pharmaceutical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Binhu Shuanghe Pharmaceutical.